A leading charity says new Hepatitis C drug Sovaldi is a huge step forward in treating the disease – but says its high price means it is not affordable for use on the NHS. Gilead's Sovaldi ...

Sovaldi, has been widely praised as a significant breakthrough and an important innovation. It offers a cure rate of around 90 per cent and, for some patients, comes with far milder side effects ...